A longitudinal study of antioxidant status in phenylketonuric patients

被引:54
|
作者
Artuch, R
Colomé, C
Sierra, C
Brandi, N
Lambruschini, N
Campistol, J
Ugarte, D
Vilaseca, MA
机构
[1] Hosp Sant Joan de Deu, Serv Bioquim, Barcelona 09850, Spain
[2] Univ Publ Navarra, Dept Estadist & IO, Pamplona, Spain
关键词
phenylketonuria; selenium; ubiquinone-10; antioxidant enzymes; dietary treatment;
D O I
10.1016/j.clinbiochem.2003.10.017
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To investigate the implications of the three main factors of the antioxidant system reported in relation to oxidative damage in phenylketonuric patients: selenium, ubiquinone-10 (Q10) and antioxidant enzymes over 3 years of metabolic follow-up. Design and methods: Longitudinal study of 46 phenylketonuric patients (age range: 6 months-34 years). Antioxidants were measured by atomic absorption spectrophotometric, chromatographic and spectrophotometric procedures. Results: Plasma selenium concentrations in phenylketonuria (PKU) were not different from those of a healthy population. Decreased plasma Q 10 concentrations were mainly related to the dietary control and the age of patients. Erythrocyte catalase activity was significantly decreased in PKU while the other enzyme activities were not different from those of a healthy population. Conclusions: Selenium status is not impaired in phenylketonuric patients under dietary treatment. Q10 values tend to decrease with increased patient age. Catalase activity was negatively associated with plasma phenylalanine values. (C) 2003 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:198 / 203
页数:6
相关论文
共 50 条
  • [21] CALCEMIC STATUS OF GERIATRIC-PATIENTS - A LONGITUDINAL-STUDY
    SORVA, A
    ELFVING, S
    SIEVERS, G
    TILVIS, RS
    [J]. GERONTOLOGY, 1992, 38 (1-2) : 87 - 91
  • [22] ANTIOXIDANT STATUS IN PATIENTS WITH TENDINOPATHY
    Hira, S.
    Arslan, R.
    Tamam, C.
    Gem, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S468 - S468
  • [23] Growth and Nutritional Status of Phenylketonuric Children and Adolescents
    Mina Ahmadzadeh
    Golbon Sohrab
    Mohammadreza Alaei
    Hassan Eini-Zinab
    Behzad mohammadpour-Ahranjani
    Samira Rastgoo
    Zahra Namkhah
    [J]. BMC Pediatrics, 22
  • [24] Phenylketonuric patients represent their disease
    Iakovou, Kostas
    Schulpis, Kleopatra
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2019, 32 (11): : 1217 - 1220
  • [25] LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study
    Belo, L
    Caslake, M
    Santos-Silva, A
    Castro, EMB
    Pereira-Leite, L
    Quintanilha, A
    Rebelo, I
    [J]. ATHEROSCLEROSIS, 2004, 177 (02) : 391 - 399
  • [26] Lipid peroxidation, antioxidant status and survival in institutionalised elderly:: A five-year longitudinal study
    Huerta, Jose M.
    Gonzalez, Sonia
    Fernandez, Serafina
    Patterson, Angeles M.
    Lasheras, Cristina
    [J]. FREE RADICAL RESEARCH, 2006, 40 (06) : 571 - 578
  • [27] Effects of Valproate Monotherapy on the Oxidant-Antioxidant Status in Mexican Epileptic Children: A Longitudinal Study
    Beltran-Sarmiento, Eduardo
    Arregoitia-Sarabia, Cindy K.
    Floriano-Sanchez, Esau
    Sandoval-Pacheco, Roberto
    Galvan-Hernandez, Diana E.
    Coballase-Urrutia, Elvia
    Carmona-Aparicio, Liliana
    Ramos-Reyna, Eduardo
    Rodriguez-Silverio, Juan
    Cardenas-Rodriguez, Noemi
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
  • [28] Characterization of tremor in phenylketonuric patients
    Pérez-Dueñas, B
    Valls-Solé, J
    Fernández-Alvarez, E
    Conill, J
    Vilaseca, MA
    Artuch, R
    Campistol, J
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 (11) : 1328 - 1334
  • [29] Characterisation of tremor in phenylketonuric patients
    Dueñas, BP
    Valls-Solé, J
    Fernández-Alvarez, E
    Conill, J
    Vilaseca, M
    Artuch, R
    Campistol, J
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 : 100 - 100
  • [30] Long-chain polyunsaturated fatty acid status in phenylketonuric patients treated with tetrahydrobiopterin
    Vilaseca, Maria A.
    Lambruschini, Nilo
    Gomez-Lopez, Lilianne
    Gutierrez, Alejandra
    Moreno, Juan
    Tondo, Mireia
    Artuch, Rafael
    Campistol, Jaume
    [J]. CLINICAL BIOCHEMISTRY, 2010, 43 (4-5) : 411 - 415